Trending on Bing
10,100 results
By Laura Baisas | Published Jan 27, 2023 9:00 AM On Thursday, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee unanimously voted to support a ...
The FDA pulled Evusheld from the market because it is not effective against more than 90% of the Covid subvariants that are currently circulating in the U.S. People with compromised immune systems ...
[1] While this case addresses access to a single product and was prompted by abortion opponents’ efforts to eliminate access to medication abortion, a loss for FDA in this case could have far ...
The proposed action levels – which are not legally set limits, but could lead to FDA enforcement action – would result in reduced exposures to lead and lessen potential health effects for ...
The FDA proposed new lead limits in baby food. Lead exposure can impair brain development and the nervous system, resulting in learning disabilities, lower IQ and behavioral difficulties.
That's how the flu vaccine is formulated each year. "FDA anticipates conducting an assessment of SARS-CoV-2 strains at least annually and to engage VRBPAC in about early June of each year ...
The Food and Drug Administration (FDA) has lifted a decades-long ban on sexually active gay and bisexual men from donating blood, overruling a restriction dating back to the 1980s AIDS crisis.
"[I]t is not apparent how CBD products could meet safety standards for dietary supplements or food additives," FDA Deputy Commissioner Dr. Janet Woodcock said in a statement. She added, "For ...
Evusheld doesn't neutralize against several omicron subvariants, the FDA says. The U.S. Food and Drug Administration said Thursday it is withdrawing its emergency use authorization of a COVID-19 ...
As part of their Closer to Zero program removing lead, arsenic, mercury and cadmium from children’s diets, the FDA released new guidelines Tuesday further limiting lead concentration in ...
The FDA is looking for the experts' take on that recommendation, as well as providing twice-annual boosters for people who are immune-compromised or over a certain age to increase their chances ...
The FDA will ask its panel of outside vaccine experts to weigh in at a meeting Thursday. The agency is expected to take their advice into consideration while deciding future vaccine requirements ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results